British Association of Dermatologists and British Photodermatology Group Guidelines for the Safe and Effective Use of Psoralen–Ultraviolet A Therapy 2015

T.C. Ling; T.H. Clayton; J. Crawley; L.S. Exton; V. Goulden; S. Ibbotson; K. McKenna; M.F. Mohd Mustapa; L.E. Rhodes; R. Sarkany; R.S. Dawe


The British Journal of Dermatology. 2016;174(1):24-55. 

In This Article

Stakeholder Involvement and Peer Review

The initial guideline development group (GDG) consisted of consultant dermatologists, a medical physicist, a nurse phototherapist and a clinical fellow in medical dermatology. The draft document was circulated to the BAD membership, the British Photodermatology Group (BPG) membership, the British Dermatological Nursing Group, the National Eczema Society, the Vitiligo Society, the Psoriasis Association, and the Psoriasis and Psoriatic Arthritis Alliance for comments, which were actively considered by the GDG and peer-reviewed by the Clinical Standards Unit of the BAD (made up of the Therapy & Guidelines Subcommittee) prior to publication.